Market Cap 4.58B
Revenue (ttm) 1.28B
Net Income (ttm) 203.55M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 15.87%
Debt to Equity Ratio 0.00
Volume 100
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 54.71M
Stochastic %K 97%
Beta 0.10
Analysts Sell
Price Target N/A

Company Profile

DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, endocrinology, gastrointestinal infections, autoimmunity, hypertension, emergency/sepsis, bone metabolism, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which d...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 39 016 1487526
Fax: 39 016 147670
Address:
Via Crescentino snc, Saluggia, Italy
Latest News on DSRLF
No data available.